Onconetix, Inc. Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased
Onconetix, Inc. (ONCO) had Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased of 4.39 thousand shares as of 2024-07-11, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased · last filed 2026-03-13
- 2024-07-11: Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 4.39K shares; Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased as first filed 372.93K shares.
| Period end | Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased | Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased as first filed |
|---|---|---|
| 2024-07-11 | 4.39K shares 10-K · filed 2026-03-13 | 372.93K shares 10-Q · filed 2024-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |